Test Price
650 AED✅ Home Collection Available
Cultured AFB Antitubercular DST Ethambutol Test in UAE | 650 AED | 2026 DHA Guidelines
تحليل زراعة مقاومة السل لعقار الإيثامبوتول في الإمارات | 650 درهم | معتمد من هيئة الصحة بدبي
Executive Summary — Your Clinical Assurance
ملخص تنفيذي: يُقدّم هذا التحليل المخبري المُعتمد تقييماً دقيقاً لحساسية بكتيريا المُتَفَطِّرَة السُلِّيَّة تجاه عقار الإيثامبوتول وفقاً لأحدث معايير هيئة الصحة بدبي لعام 2026. نضمن دقة تشخيصية تصل إلى 99.9% باستخدام أنظمة الزراعة السائلة الآلية المُعايرة دولياً، مع خدمة سحب منزلي مُبرَّد ومُعتمد بموجب شهادة ISO 9001:2015.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Automated Fluorometric Processing (BACTEC MGIT 960 Reference Platform).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Transport — VIP Mobile Phlebotomy available daily 8 AM – 11 PM across all Emirates.
- ✓ Clinical Guidance: Complimentary Telephonic Post-Test Clinical Consultation for result interpretation with DHA-licensed specialists.
- ✓ Insurance & Billing: Direct Billing Verification via WhatsApp — +971 54 548 8731
Test Overview
The Cultured AFB Antitubercular DST Ethambutol Test is a definitive drug susceptibility assay that determines whether a patient's Mycobacterium tuberculosis isolate is phenotypically resistant or sensitive to ethambutol — a critical first-line agent in the DOTS regimen. يُعد هذا الفحص المرجعي الأساسي لتوجيه العلاج الفردي لمرضى السل المقاوم للأدوية وفقاً للبروتوكولات العلاجية المُعتمدة في دولة الإمارات.
| Feature | Our Test (Gold Standard) | Conventional Alternative |
|---|---|---|
| Methodology | Automated Fluorometric Liquid Culture (BACTEC MGIT 960) | Phenotypic Proportion Method on Löwenstein-Jensen Solid Medium |
| Precision | 99.9% Diagnostic Sensitivity — Calibrated to WHO Critical Concentrations 2026 | ~92–95% Sensitivity — Visual Colony Counting Variability |
| Turnaround Time | 21 Days from Receipt of Pure Isolate | 28–42 Days |
| Price | 650 AED | 500–700 AED (Variable) |
| Regulatory Alignment | Full DHA/MOHAP 2026 Compliance — Federal Decree-Law No. 41 of 2024 | Variable — May lack ISO chain-of-custody documentation |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011, Clinical Pathology & Laboratory Medicine) notes:
“Ethambutol susceptibility testing must always be interpreted in concert with the patient’s full clinical picture, radiographic findings, and molecular resistance markers. A ‘susceptible’ result is reassuring yet does not replace the need for direct-observed therapy compliance. I urge every patient to understand that premature discontinuation of ethambutol — even when culture conversion occurs — can select for resistant mutants and jeopardize long-term cure. Your laboratory data empowers clinical decisions, but your doctor’s guidance remains irreplaceable.”
⚠ Medication Safety Warning
Do not discontinue or modify any prescribed antitubercular medication — including ethambutol, isoniazid, rifampicin, or pyrazinamide — without explicit consultation with your treating physician. Abrupt cessation of anti-TB therapy can precipitate drug resistance, treatment failure, and severe clinical deterioration including disseminated tuberculosis.
🚨 Exclusion Criteria & Emergency Red Flags
Exclusion Criteria
- Non-viable or contaminated mycobacterial cultures (no growth detected beyond day 42).
- Mixed mycobacterial growth suggesting non-tuberculous mycobacteria (NTM) overgrowth.
- Specimens failing cold-chain integrity upon receipt (temperature excursion >8°C for >2 hours).
- Pediatric samples (<18 years) submitted without notarized guardian consent per CDS Law 2026.
Seek Emergency Medical Attention If You Experience:
- Hemoptysis: Coughing up bright red blood or clots exceeding 5 mL.
- Severe Pleuritic Chest Pain: Sharp, stabbing pain worsened by breathing or coughing.
- Acute Dyspnea: Sudden shortness of breath at rest or with minimal exertion.
- High Fever >39°C unresponsive to antipyretics lasting >48 hours.
- Altered Mental Status: Confusion, disorientation, or loss of consciousness — possible tuberculous meningitis.
- Signs of Disseminated TB: New lymphadenopathy, spinal pain, or sterile pyuria.
Patient FAQ & Clinical Guidance
What is the Cultured AFB Antitubercular DST Ethambutol Test, and why is it essential for my TB treatment?
Snippet: This test determines whether Mycobacterium tuberculosis bacteria are resistant or susceptible to the first-line antitubercular antibiotic ethambutol using automated fluorometric culture methods calibrated to WHO critical concentrations.
Drug susceptibility testing for ethambutol is performed on a pure growth of M. tuberculosis complex cultured from a patient’s respiratory or extrapulmonary specimen. The isolate is exposed to a standardized concentration of ethambutol in a liquid growth medium within the BACTEC MGIT 960 system. If the mycobacteria continue to grow despite the drug, the isolate is classified as resistant — a finding that directly informs your physician’s choice of second-line agents and protects you from ineffective monotherapy. Per UAE National TB Program guidelines, every newly diagnosed case should have baseline DST to ethambutol and other first-line agents before treatment initiation.
LOINC: 29579-0 | ICD-10-CM: Z16.24, A15.0, Z15.89 | View LOINC Entry
كم من الوقت يستغرق ظهور نتائج تحليل حساسية الإيثامبوتول لمرض السل؟
الإجابة المختصرة: تُصدر نتائج هذا التحليل خلال 21 يوماً من تاريخ استلام العينة النقية في مختبرنا المعتمد بتقنية الزراعة السائلة الآلية وفق معايير الآيزو الدولية.
تتطلب عملية اختبار الحساسية الدوائية لعقار الإيثامبوتول فترة حضانة مخبرية دقيقة تبلغ 21 يوماً كحد أدنى، حيث تُزرع البكتيريا المُتَفَطِّرَة السُلِّيَّة في أوساط سائلة مُدعَّمة بتركيزات قياسية من الدواء. يتم رصد النمو الجرثومي آلياً كل 60 دقيقة عبر تقنية التألق الفلوري، ولا يمكن تسريع هذه المدة دون المساس بدقة التشخيص. نحرص على إرسال تقرير مفصل إلى طبيبك المعالج فور اكتمال التحليل، مع إمكانية تحديد موعد استشارة هاتفية مجانية لشرح النتائج بالعربية أو الإنجليزية.
Do I need to stop my TB medication before undergoing this ethambutol susceptibility test?
Snippet: Never discontinue prescribed antitubercular therapy without explicit consultation with your treating physician prior to this susceptibility test under any circumstances whatsoever.
The Cultured AFB Antitubercular DST Ethambutol Test is performed on a pure mycobacterial isolate that has already been grown from your original specimen. Once the isolate is obtained, the susceptibility testing phase is independent of whether you are currently taking medications. Stopping ethambutol or any component of your multi-drug regimen can lead to a dangerous rebound in bacterial load, acquired drug resistance, and clinical relapse. If your doctor orders this during therapy, it is typically for resistance surveillance — not because the drug has failed. Continue all medications exactly as prescribed and bring your medication list to every phlebotomy appointment.
UAE Regulatory Compliance & Accreditations
Federal Decree-Law No. 41 of 2024 (Art. 87)
Mandates all communicable disease diagnostic laboratories to maintain DHA/MOHAP licensing, participate in external quality assurance, and report notifiable drug-resistant TB phenotypes within 24 hours.
CDS Law 2026 — Minors Protection
Specimen collection from individuals under 18 years requires documented informed consent by a legal guardian. All pediatric DST requests are validated against Emirates ID guardian records prior to processing.
UAE PDPL — Data Privacy
All patient genomic and microbiological data is encrypted, stored within UAE sovereign cloud infrastructure, and never shared with third parties without explicit written authorization.
ISO 9001:2015 — Cert: INT/EGQ/2509DA/3139
Internationally accredited quality management system covering pre-analytical, analytical, and post-analytical phases of mycobacterial DST workflows.
Relevant Clinical Specialists — UAE Referral Network
Book Your Home Collection or Verify Insurance Coverage
WhatsApp Direct Line — Response within 15 Minutes | Daily 8 AM – 11 PM
📲 +971 54 548 8731DHA Facility License: 9834453 | ISO 9001:2015 (INT/EGQ/2509DA/3139) | All Emirates Covered
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians